НовостиBenzingaLiminatus Pharma Regains Compliance With Nasdaq’s Minimum Bid Price Rule Liminatus Pharma Regains Compliance With Nasdaq’s Minimum Bid Price Rule Benzinga 2026.09.29 13:05 (GMT+0) Открыть на Benzinga Другие новости